The Living Thing / Notebooks :

Drugs

/images/smbc_drugs.png

Nothing to say here yet. Eventually I’d like to talk about medicalisation, and how drugs for diseases are OK, drugs for things that aren’t diseases are denounced, and what a disease is is negotiated based on… what?

Refs

Astr10
Astrid, N. (2010) Is Caffeine a Cognitive Enhancer?. Journal of Alzheimer’s Disease, (S1), 85–94. DOI.
BeMu88
Becker, G. S., & Murphy, K. M.(1988) A theory of rational addiction. The Journal of Political Economy, 675–700.
DrGu12
Dregan, A., & Gulliford, M. C.(2012) Is Illicit Drug Use Harmful to Cognitive Functioning in the Midadult Years? A Cohort-based Investigation. American Journal of Epidemiology, 175(3), 218–227. DOI.
Mcke04
McKenna, D. J.(2004) Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics, 102(2), 111–129. DOI.
Nutt09
Nutt, D. J.(2009) Equasy — An overlooked addiction with implications for the current debate on drug harms. Journal of Psychopharmacology, 23(1), 3–5. DOI.
OlBa96
Olekalns, N., & Bardsley, P. (1996) Rational Addiction to Caffeine: An Analysis of Coffee Consumption. The Journal of Political Economy, 104, 1100.
RaBr15
Rae, C. D., & Bröer, S. (2015) Creatine as a booster for human brain function How might it work?. Neurochemistry International, 89, 249–259. DOI.
SLSM07
Santos, R. G., Landeira-Fernandez, J., Strassman, R. J., Motta, V., & Cruz, A. P. M.(2007) Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. Journal of Ethnopharmacology, 112(3), 507–513. DOI.
SCBS17
Schartner, M. M., Carhart-Harris, R. L., Barrett, A. B., Seth, A. K., & Muthukumaraswamy, S. D.(2017) Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin. Scientific Reports, 7, 46421. DOI.
Smit05
Smith, A. (2005) Effects of repeated doses of caffeine on mood and performance of alert and fatigued volunteers. Journal of Psychopharmacology, 19(6), 620–626. DOI.
Stra95
Strassman, R. J.(1995) Human psychopharmacology of N,N-dimethyltryptamine. Behavioural Brain Research, 73(1–2), 121–124. DOI.
WhBa11
White, J., & Batty, G. D.(2011) Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British Cohort Study. Journal of Epidemiology and Community Health, jech-2011-200252. DOI.
WhGB12
White, J. W., Gale, C. R., & Batty, G. D.(2012) Intelligence quotient in childhood and the risk of illegal drug use in middle-age: the 1958 National Child Development Survey. Annals of Epidemiology, 22(9), 654–657. DOI.